PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
22-Mar-2021 Drägerwerk AG & Co. KGaA: Dräger announces the results of its Offer in respect of its 566,819 Profit Participation Certificates (Genussscheine) Series D (ISIN: DE0005550719) Drägerwerk AG & Co. KGaA
22-Mar-2021 Evotec and Takeda enter strategic RNA targeting drug discovery and development alliance Evotec SE
22-Mar-2021 Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of UCDs and MSUD RELIEF THERAPEUTICS Holdings AG
19-Mar-2021 PAION AG ANNOUNCES FULLY UNDERWRITTEN RIGHTS ISSUE OF ALMOST EUR 8 MILLION AND PUBLISHES PRELIMINARY, UNAUDITED KEY GROUP FINANCIALS FOR 2020 PAION AG
19-Mar-2021 PAION AG TO ISSUE APPROX. 5 MILLION SHARES AT EUR 1.54 PER SHARE IN CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS PAION AG
19-Mar-2021 Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini Heidelberg Pharma AG
19-Mar-2021 Tetra Pak and Rockwell Automation collaborate to advance performance for powder manufacturers Tetra Pak and Rockwell Automation Inc.
19-Mar-2021 Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting Santhera Pharmaceuticals
19-Mar-2021 HORIBA launches new website resource centre dedicated to supporting Academia HORIBA UK Limited announces
19-Mar-2021 UK and EU regulatory agencies confirm COVID-19 Vaccine AstraZeneca is safe and effective AstraZeneca
19-Mar-2021 Chiesi USA Announces Commercial Launch of Pharmaxis’ Cystic Fibrosis Drug Bronchitol Pharmaxis
19-Mar-2021 2021 PM Society Awards – Winners Announced PM Society Awards
19-Mar-2021 Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform Envision Pharma Group
19-Mar-2021 Envision Pharma Group appoints Manish Goel as Global Head of Envision Technology Solutions Envision Pharma Group
18-Mar-2021 Invite from Justin Mason-Home, Chair at SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients 2021 SMi Group
18-Mar-2021 ONK Therapeutics Strengthens its Cell Therapy Manufacturing Process with License for EBV-LCL Feeder Cell Line from NIH to Enhance NK Cell Expansion ONK Therapeutics
18-Mar-2021 AbbVie Calls on Students with Cystic Fibrosis to Apply for the AbbVie CF Scholarship for the 2021-2022 Academic School Year AbbVie
18-Mar-2021 Evotec SE to announce results for fiscal year 2020 on 25 March 2021 Evotec SE
18-Mar-2021 TARGETED ORAL MONOTHERAPY CALQUENCE (ACALABRUTINIB) RECOMMENDED BY NICE FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) AstraZeneca
18-Mar-2021 First new cholesterol-lowering oral treatments in over a decade, NILEMDO®▼ (bempedoic acid) and NUSTENDI®▼(bempedoic acid / ezetimibe), approved for use on the NHS Daiichi Sankyo